Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital.

Posted on January 9, 2020 by admin
Dean and CEO of Johns Hopkins Medicine Paul Rothman

December 11, 2018- by Steven E. Greer, MD

Ranking colleges and medical centers is a futile, highly subjective, and ludicrous endeavor. Nevertheless, Continue reading →

Posted in - Policy, Cardiac surgery, Cardiology, Columbia, Johns Hopkins, Pediatrics | 3 Comments

Don Berwick, MD: Waste in the American Healthcare System

Posted on January 9, 2020 by admin

Dr. Berwick, former Director of CMS and former President and CEO of IHI, discusses the percentage Continue reading →

Posted in CMS, Congress, Harvard | Leave a comment

Benjamin Sommers, MD PhD: Expansion of Medicaid and impact on mortality rates

Posted on January 9, 2020 by admin

September 7, 2012

Posted in CMS, Harvard | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Posted on January 9, 2020 by admin

February 27, 2017- interviewed by Steven E. Greer, MD

We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber, Continue reading →

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

Preventing HIV infection

Posted on January 9, 2020 by admin

July 28, 2014- Interviewed by Steven E. Greer, MD

Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper he co-wrote Continue reading →

Posted in - Biotech, - NEJM, - Pharma, General surgery, Harvard, Infectious disease, Primary care medicine | Leave a comment

Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome

Posted on January 7, 2020 by admin

January 20, 2016- Produced, Interviewed by Steven E. Greer, MD

We interviewed Anthony Lembo, MD of The Beth Israel Deaconess Hospital to discuss his Continue reading →

Posted in - NEJM, - Pharma, Gastroenterology and liver, Harvard | Leave a comment

Paul Richardson, MD: Current Therapies for Multiple Myeloma

Posted on January 7, 2020 by admin

December 15, 2015- Interviewed by Steven Greer, MD

Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber Continue reading →

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

The 23andMe TV ads are misleading

Posted on January 4, 2020 by admin

April 22, 2019- by Steven E. Greer, MD Continue reading →

Posted in FDA, Genetics | Comments Off on The 23andMe TV ads are misleading

How did a small academic lab succeed where big medical device companies failed?

Posted on January 1, 2020 by admin

July 5, 2014- Interviewed by Steven E. Greer, MD

The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” Continue reading →

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

A proposal to screen for mass shooters

Posted on January 1, 2020 by admin

August 5, 2019- by Steven E. Greer, MD

President Trump today announced plans to have the Department of Justice create guidelines Continue reading →

Posted in - Opinion, - Policy, CDC, Congress, Psychology Psychiatry, Trauma Surgery | Comments Off on A proposal to screen for mass shooters

What I Did for Summer 2019

Posted on December 22, 2019 by admin

Posted in - Opinion | Comments Off on What I Did for Summer 2019

Books I am reading

Posted on December 20, 2019 by admin

November 17, 2019- by Steven E. Greer, MD Continue reading →

Posted in Uncategorized | Leave a comment

Triple Therapy for Cystic Fibrosis

Posted on December 12, 2019 by admin

October 18, 2018- interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, FDA, Genetics, Infectious disease, Internal Medicine, National Jewish Health, Pediatrics, Pulmonology | Leave a comment

How the FDA regulates compounding pharmacies

Posted on November 14, 2019 by admin

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the Continue reading →

Posted in - Policy, FDA | Leave a comment

Go Vegan?

Posted on November 12, 2019 by admin

November 3, 2019- by Steven E. Greer, MD

My diet is much better than it used to be. I eat a lot more plants and almost no red meat. I snack Continue reading →

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Harvard, Internal Medicine, Oncology, Pediatrics, Sports medicine | Comments Off on Go Vegan?

Newsmax discussion of The Medical Advocate

Posted on October 21, 2019 by admin

October 14, 2019- This is my appearance today on Newsmax. Continue reading →

Posted in - Policy, CMS, Congress, FDA | Comments Off on Newsmax discussion of The Medical Advocate

Images from the Trump Medicare rally

Posted on October 20, 2019 by admin

October 3, 2019 Continue reading →

Posted in - Policy, CMS, Congress | Comments Off on Images from the Trump Medicare rally

I can’t get no satisfaction (from TAVR)

Posted on October 18, 2019 by admin

Update April 6, 2019- An expert source told us that Mick Jagger did have genuine aortic stenosis. Continue reading →

Posted in - Medical Devices, - Opinion, Cardiac surgery, Cardiology, FDA | Comments Off on I can’t get no satisfaction (from TAVR)

Major disruption coming to hospitals in 2020

Posted on October 18, 2019 by admin

August 2, 2019- by Steven E. Greer, MD

President Trump recently signed Continue reading →

Posted in - Policy, CMS, Congress | Comments Off on Major disruption coming to hospitals in 2020

CMMI Director leaves after Healthcare Channel investigates

Posted on October 1, 2019 by admin

September 29, 2013-By Steven E. Greer, MD

In June of 2012, The Healthcare Channel published an influential Op-Ed in the WSJ exposing Continue reading →

Posted in CMS | Leave a comment